Published in World J Gastroenterol on April 07, 2014
Prognostic value of three different lymph node staging systems in the survival of patients with gastric cancer following D2 lymphadenectomy. Tumour Biol (2016) 0.82
Clinical significance of lymphadenectomy in patients with gastric cancer. World J Gastrointest Oncol (2016) 0.79
A new predictive model combined of tumor size, lymph nodes count and lymphovascular invasion for survival prognosis in patients with lymph node-negative gastric cancer. Oncotarget (2016) 0.75
Evaluation of rational extent lymphadenectomy for local advanced gastric cancer. Chin J Cancer Res (2016) 0.75
Clinicopathologic implication of meticulous pathologic examination of regional lymph nodes in gastric cancer patients. PLoS One (2017) 0.75
Impact on long-term survival of the number of lymph nodes resected in patients with pT1N0 gastric cancer after R0 resection: A multicenter study in China. Medicine (Baltimore) (2016) 0.75
Survival after Gastrectomy in Node-Negative Gastric Cancer: A Review and Meta-Analysis of Prognostic Factors. Med Sci Monit (2015) 0.75
Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer (2011) 16.97
Gastric cancer. Lancet (2009) 7.27
Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group. Br J Cancer (1999) 6.76
Hospital lymph node examination rates and survival after resection for colon cancer. JAMA (2007) 4.55
Impact of total lymph node count on staging and survival after gastrectomy for gastric cancer: data from a large US-population database. J Clin Oncol (2005) 2.60
A multicentric Western analysis of prognostic factors in advanced, node-negative gastric cancer patients. Ann Surg (2010) 2.27
Sentinel node mapping for gastric cancer: a prospective multicenter trial in Japan. J Clin Oncol (2013) 1.79
Clinicopathologic characteristics and prognostic factors in 10 783 patients with gastric cancer. Gastric Cancer (1998) 1.79
Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer. Cancer (2006) 1.78
Evaluation of the New International Union Against Cancer TNM staging for gastric carcinoma. Cancer (2000) 1.77
Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol (2006) 1.69
Lymphadenectomy in gastric carcinoma. A prospective and prognostic study. Arch Surg (1992) 1.53
Residual tumor (R) classification and prognosis. Semin Surg Oncol (1994) 1.51
How many nodes must be examined to accurately stage gastric carcinomas? Results from a population based study. Cancer (2002) 1.50
Suitability of 7th UICC N stage for predicting the overall survival of gastric cancer patients after curative resection in China. Ann Surg Oncol (2010) 1.47
Classification of lymph node metastases from gastric cancer: comparison between N-site and N-number systems. Our experience and review of the literature. Am Surg (2007) 1.47
Prognostic effect of lymph node micrometastasis in patients with histologically node-negative gastric cancer. Ann Surg Oncol (2002) 1.40
Prognostic factors of node-negative gastric carcinoma: univariate and multivariate analyses. J Am Coll Surg (1997) 1.31
Body mass index determines the success of lymph node dissection and predicts the outcome of gastric carcinoma patients. Oncology (2000) 1.26
JGCA (The Japan Gastric Cancer Association). Gastric cancer treatment guidelines. Jpn J Clin Oncol (2004) 1.21
Effect of lymph node number on survival of patients with lymph node-negative gastric cancer according to the 7th edition UICC TNM system. PLoS One (2012) 1.20
Influence of surgical subspecialty training on in-hospital mortality for gastrectomy and colectomy patients. Ann Surg (2003) 1.14
Prognostic indicators in node-negative advanced gastric cancer patients. J Surg Oncol (2010) 1.11
The significances of lymph node micrometastasis and its correlation with E-cadherin expression in pT1-T3N0 gastric adenocarcinoma. J Surg Oncol (2008) 1.04
Clinical implication of an insufficient number of examined lymph nodes after curative resection for gastric cancer. Cancer (2012) 1.03
Impact of lymphovascular invasion in patients with stage I gastric cancer. Surgery (2009) 1.00
Pathology practice patterns affect lymph node evaluation and outcome of colon cancer: a population-based study. Ann Oncol (2006) 0.99
Survival predictors in patients with node-negative gastric carcinoma. J Gastroenterol Hepatol (2007) 0.99
Enhancement the prediction of postoperative survival in gastric cancer by combining the negative lymph node count with ratio between positive and examined lymph nodes. Ann Surg Oncol (2009) 0.99
Surgical treatment of advanced gastric cancer: Japanese perspective. Dig Surg (2007) 0.98
An evaluation of the effectiveness of extended lymph node dissection in patients with gastric cancer: a retrospective study of 1403 cases at a single institution. J Surg Res (2002) 0.97
Number of lymph nodes examined and its impact on colorectal cancer staging. Am Surg (2006) 0.95
Guideline recommended gastric cancer care in the elderly: insights into the applicability of cancer trials to real world. Ann Surg Oncol (2010) 0.94
Inadequacy of lymph node staging in gastric cancer patients: a population-based study. Ann Surg Oncol (2005) 0.92
Prognosis of gastric cancer patients with node-negative metastasis following curative resection: outcomes of the survival and recurrence. Can J Gastroenterol (2008) 0.90
Significant prognostic factors in patients with node-negative gastric cancer. Int Surg (2000) 0.88
Ratio between negative and positive lymph nodes is suitable for evaluation the prognosis of gastric cancer patients with positive node metastasis. PLoS One (2012) 0.83
Prognostic impact of dissected lymph node count on patients with node-negative gastric cancer. World J Gastroenterol (2009) 0.82
Is there a role for surgery with adequate nodal evaluation alone in gastric adenocarcinoma? J Gastrointest Surg (2011) 0.80
A descriptive analysis of gastric cancer specimen processing techniques. J Surg Oncol (2011) 0.77